Clinical <scp>U</scp> pdate on the <scp>M</scp> anagement of <scp>A</scp> trial <scp>F</scp> ibrillation
Ilya Danelich(AstraZeneca (South Korea)), Jo E. Rodgers(Loyola University Medical Center), Ian B. Hollis(University of North Carolina Hospitals), Brent N. Reed(University of Maryland, Baltimore), Abigail Cook(Loyola Medicine)
Cited by 20
Related Papers
Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levels
|Journal of Thrombosis and Haemostasis|2013|231
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40